<DOC>
	<DOCNO>NCT01080209</DOCNO>
	<brief_summary>This study evaluate biodegradation brimonidine tartrate posterior segment drug delivery system .</brief_summary>
	<brief_title>Safety Extension Study Evaluate Biodegradation Brimonidine Tartrate Posterior Segment Drug Delivery System</brief_title>
	<detailed_description />
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<criteria>Received recent sham active study treatment intravitreal Brimo PS DDS® later 36 month prior entry study either complete previous study , exit early previous study reason Applicable study : Previous Allergan intravitreal Brimo PS DDS® treatment study None</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
</DOC>